Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Azimuth Opportunity

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$62M
Portfolio companies 4
Lead investments 3
Exits 4
Key employees Soon
Stages of investment
Private Equity

Areas of investment

  • Biotechnology
  • Medical
  • Pharmaceutical
  • Genetics
  • Medical Device
Summary

The company was established in North America in United States. The leading representative office of defined VC is situated in the New York.

The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2008. Speaking about the real fund results, this VC is 80 percentage points more often commits exit comparing to other organizations. This Azimuth Opportunity works on 71 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2006. The common things for fund are deals in the range of 50 - 100 millions dollars.

Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight MicroVision, Solexa, Encysive Pharmaceuticals. Among the most popular fund investment industries, there are Pharmaceutical, Genetics.

The usual cause for the fund is to invest in rounds with 1 partaker. Despite the Azimuth Opportunity, startups are often financed by Walsin Lihwa, ValueAct Capital, General Electric Pension Trust. In the next rounds fund is usually obtained by Hudson Capital Group, Enable Capital Management.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Azimuth Opportunity:
Typical Co-investors
Azimuth Opportunity is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Azimuth Opportunity:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ALAN AMC Beijing, Beijing, China
Bonnier Stockholm, Stockholm County, Sweden
Brick & Mortar Ventures California, San Francisco, United States
DRW Venture Capital Chicago, Illinois, United States
ES NETWORKS Japan, Tokyo
Government of Singapore -
Heyokha Brothers China, Hong Kong, Hong Kong Island
Lee Equity Partners New York, New York, United States
N-tech Ahmedabad, Gujarat, India
Nextblue -
NextWave Ventures California, San Diego, United States
Ningbo Xuri Lamp Decoration China, Xiangshan, Zhejiang
North Country Angels Burlington, United States, Vermont
Portuguese Public Funding -
Shanghai Jugu Equity Investment Fund China, Shanghai
Symmetry Peak Management Pennsylvania, Radnor, United States
Taubman Capital New York, New York, United States
The Quercus Trust -
The Renewable Energy Corporation Central, Central Region, Singapore

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MicroVision

Consumer Electronics
Laser
Software
$60M24 Aug 2010 Washington, United States

Omeros

Biotechnology
Health Care
Pharmaceutical
$40M29 Jul 2010 Seattle, Washington, United States

Encysive Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$75M19 Oct 2006 Houston, Texas, United States

Solexa

Biotechnology
Genetics
Medical
Medical Device
$75M20 Sep 2006 Hayward, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Azimuth Opportunity?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: